KMT2A and acute myeloid leukemia: We also observed no significant difference between MLL/AF9 blasts and HPCs with respect to glycolysis; but glycolysis capacity was significantly upregulated in MLL/AF9 cells, indicating higher metabolic plasticity in MLL/AF9 AML cells than HPCs.